Literature DB >> 26543617

Minimally invasive is the future of left ventricular assist device implantation.

George Makdisi1, I-Wen Wang1.   

Abstract

There have been many factors that have allowed for progressive improvement in outcomes and lower complication rates. These include the improvement in left ventricular assist device (LVAD) technologies, combined with better understanding of patient management, all these. Nowadays the numbers of LVAD implantations exceed the number of annual heart transplants worldwide. Minimally invasive procedures are shown to improve the surgical outcome in both LVAD insertion and replacement. These minimally invasive techniques can be grouped grossly into shifting from on-pump to off-pump implantation, alternative access for implantation other than sternotomy, and a combination of both, which should be the ultimate aim of minimally invasive LVAD implantation. Here we describe the alternative techniques and configurations of minimally invasive and sites of implantation.

Entities:  

Keywords:  Left ventricular assist device (LVAD); minimally invasive; off-pump; ventricular assist device (VAD)

Year:  2015        PMID: 26543617      PMCID: PMC4598531          DOI: 10.3978/j.issn.2072-1439.2015.08.30

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  40 in total

1.  Implantation of the Jarvik 2000 left ventricular assist device without the use of cardiopulmonary bypass.

Authors:  O H Frazier
Journal:  Ann Thorac Surg       Date:  2003-03       Impact factor: 4.330

2.  Minimally invasive thoracic left ventricular assist device implantation; case series demonstrating an integrated multidisciplinary strategy.

Authors:  Chad E Wagner; Julian S Bick; Jason Kennedy; Nicholas Haglund; Matthew Danter; Mary E Davis; Andrew Shaw; Simon Maltais
Journal:  J Cardiothorac Vasc Anesth       Date:  2014-11-11       Impact factor: 2.628

3.  Left thoracotomy HeartWare implantation with outflow graft anastomosis to the descending aorta: a simplified bridge for patients with multiple previous sternotomies.

Authors:  Ramanan Umakanthan; Nicholas A Haglund; John M Stulak; Lyle D Joyce; Rashid Ahmad; Mary E Keebler; Simon Maltais
Journal:  ASAIO J       Date:  2013 Nov-Dec       Impact factor: 2.872

4.  Left ventricular assist system as a bridge to myocardial recovery.

Authors:  O H Frazier; T J Myers
Journal:  Ann Thorac Surg       Date:  1999-08       Impact factor: 4.330

5.  Second INTERMACS annual report: more than 1,000 primary left ventricular assist device implants.

Authors:  James K Kirklin; David C Naftel; Robert L Kormos; Lynne W Stevenson; Francis D Pagani; Marissa A Miller; Karen L Ulisney; J Timothy Baldwin; James B Young
Journal:  J Heart Lung Transplant       Date:  2010-01       Impact factor: 10.247

6.  Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients.

Authors:  James K Kirklin; David C Naftel; Robert L Kormos; Lynne W Stevenson; Francis D Pagani; Marissa A Miller; J T Baldwin; J Timothy Baldwin; James B Young
Journal:  J Heart Lung Transplant       Date:  2013-02       Impact factor: 10.247

7.  Off-pump insertion of continuous flow left ventricular assist devices.

Authors:  Craig H Selzman; Brett C Sheridan
Journal:  J Card Surg       Date:  2007 Jul-Aug       Impact factor: 1.620

Review 8.  Role of pharmacologic tests in the treatment of primary pulmonary hypertension.

Authors:  N Galiè; G Ussia; P Passarelli; R Parlangeli; A Branzi; B Magnani
Journal:  Am J Cardiol       Date:  1995-01-19       Impact factor: 2.778

9.  A less invasive approach to axial flow pump insertion.

Authors:  Igor D Gregoric; Saverio La Francesca; Tim Myers; William Cohn; Pranav Loyalka; Biswajit Kar; Courtney Gemmato; O H Frazier
Journal:  J Heart Lung Transplant       Date:  2008-04       Impact factor: 10.247

10.  Initial experience with routine less invasive implantation of HeartMate II left ventricular assist device without median sternotomy.

Authors:  Anelechi C Anyanwu; Shinobu Itagaki; Sean Pinney; David H Adams
Journal:  Eur J Cardiothorac Surg       Date:  2014-03-12       Impact factor: 4.191

View more
  6 in total

1.  How to establish a successful destination therapy ventricular assist device program.

Authors:  George Makdisi; Peter B Makdisi; Hartmuth B Bittner
Journal:  J Thorac Dis       Date:  2017-04       Impact factor: 2.895

Review 2.  New horizons of non-emergent use of extracorporeal membranous oxygenator support.

Authors:  George Makdisi; Peter B Makdisi; I-Wen Wang
Journal:  Ann Transl Med       Date:  2016-02

3.  Ethical challenges and terminal deactivation of left ventricular assist device.

Authors:  Tony Makdisi; George Makdisi
Journal:  Ann Transl Med       Date:  2017-08

4.  Commentary: Less-invasive approaches to big complex problems in patients with end-stage heart disease.

Authors:  Stephanie N Nguyen; Tom C Nguyen
Journal:  JTCVS Tech       Date:  2020-09-16

Review 5.  Minimally invasive versus conventional continuous-flow left ventricular assist device implantation for heart failure: a meta-analysis.

Authors:  Bufan Zhang; Shaohua Guo; Zean Fu; Zhigang Liu
Journal:  Heart Fail Rev       Date:  2021-04-03       Impact factor: 4.654

6.  Commentary: Sometimes there is a simpler route!

Authors:  Mevlüt Çelik; Simon Maltais
Journal:  JTCVS Tech       Date:  2020-09-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.